Triductan MB 60 tabl 35mg Trimetazidine dihydrochloride Тридуктан МВ

Triductan (trimetazidine)

Triductan contains the active ingredient trimetazidine, anti-ischemic / antianginal agent.

Triductan MB Indications

Cardiology: long-term treatment of angina, prevention of angina attacks (as monotherapy or in combination with other drugs).
Otolaryngology: treatment of cochlear-vestibular disorders of ischemic origin, such as dizziness, tinnitus, hearing loss.
Ophthalmology: chorioretinal disorders of ischemic origin.

Dosage & Administration

Triductan designate the interior of 1 tablet 3 times a day with meals.
Triductan is designate for the interior of 1 tablet 2 times a day, morning and evening during meals, washed down with a glass of water. The drug is intended for long-term use. If necessary, a treatment plan can be reviewed after 3 months.
Duration of treatment is determined individually.

Contradictions

Increased individual sensitivity to the drug.

Browse more ear treatment available with international delivery.